Finance

Beta
Lists
524404:BOM
Marksans Pharma Ltd
₹233.10
-2.59%
(-6.20) 1D
Jun 5, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524404...
Open
₹240.00
High
₹244.15
Low
₹230.50
Mkt. cap
105.81B
Avg. vol.
202.43K
Volume
134.50K
P/E ratio
25.28
52-wk high
₹270.60
52-wk low
₹156.00
EPS
₹9.22
Shares outstanding
409.31M
No. of employees
2K
Open
₹240.00
High
₹244.15
Low
₹230.50
Mkt. cap
105.81B
Avg. vol.
202.43K
Volume
134.50K
P/E ratio
25.28
52-wk high
₹270.60
52-wk low
₹156.00
EPS
₹9.22
Shares outstanding
409.31M
No. of employees
2K
News stories
From sources across the web
About Marksans Pharma Ltd
CEOMark B. Saldanha
Employees1.84K
Founded1992
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.20B
7.20B
7.54B
8.56B
Cost of goods sold
2.62B
3.09B
3.16B
3.91B
Cost of revenue
2.62B
3.09B
3.16B
3.91B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
983.85M
1.04B
1.12B
1.07B
Operating expense
2.81B
2.94B
3.02B
2.94B
Total operating expenses
5.43B
6.03B
6.18B
6.85B
Operating income
770.22M
1.18B
1.36B
1.71B
Other non operating income
94.14M
215.72M
201.44M
103.75M
EBT including unusual items
765.98M
1.33B
1.51B
2.00B
EBT excluding unusual items
765.98M
1.33B
1.51B
2.00B
Income tax expense
183.96M
341.95M
369.34M
509.66M
Effective tax rate
24.02%
25.65%
24.52%
25.48%
Other operating expenses
1.60B
1.64B
1.65B
1.63B
Net income
583.17M
982.50M
1.13B
1.48B
Net profit margin
9.41%
13.64%
15.01%
17.30%
Earnings per share
-
-
2.50
3.27
Interest and investment income
-
-
-
-
Interest expense
-60.65M
-58.15M
-59.35M
-63.10M
Net interest expenses
-60.65M
-58.15M
-59.35M
-63.10M
Depreciation and amortization charges
231.01M
269.16M
243.27M
242.87M
EBITDA
910.36M
1.43B
1.50B
1.96B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more